Wedbush Securities’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-127,200
| Closed | -$44K | – | 914 |
|
|
2016
Q4 | $44K | Sell |
127,200
-35,000
| -22% | -$12.1K | 0.01% | 784 |
|
|
2016
Q3 | $88K | Buy |
162,200
+10,200
| +7% | +$5.53K | 0.01% | 762 |
|
|
2016
Q2 | $88K | Buy |
152,000
+9,560
| +7% | +$5.54K | 0.01% | 704 |
|
|
2016
Q1 | $208K | Buy |
142,440
+15,440
| +12% | +$22.5K | 0.04% | 579 |
|
|
2015
Q4 | $406K | Hold |
127,000
| – | – | 0.07% | 311 |
|
|
2015
Q3 | $794K | Buy |
127,000
+17,500
| +16% | +$109K | 0.16% | 149 |
|
|
2015
Q2 | $1.09M | Buy |
109,500
+33,000
| +43% | +$328K | 0.2% | 113 |
|
|
2015
Q1 | $564K | Buy |
76,500
+66,000
| +629% | +$487K | 0.1% | 241 |
|
|
2014
Q4 | $56K | Sell |
10,500
-15,000
| -59% | -$80K | 0.01% | 671 |
|
|
2014
Q3 | $128K | Buy |
25,500
+7,000
| +38% | +$35.1K | 0.02% | 619 |
|
|
2014
Q2 | $124K | Buy |
+18,500
| New | +$124K | 0.02% | 595 |
|